Cardiotoxicity and pro-inflammatory effects of the immune checkpoint inhibitor Pembrolizumab associated to TrastuzumabVincenzo Quagliariello, Nicola Maurea, Margherita Passariello et al.|International Journal of Cardiology|2019Cited by 64
In the Era of Cardiovascular–Kidney–Metabolic Syndrome in Cardio-Oncology: From Pathogenesis to Prevention and TherapyVincenzo Quagliariello, Nicola Maurea, Massimiliano Berretta et al.|Cancers|2025Cited by 25
Glucagon-like Peptide 1 Receptor Agonists in Cardio-Oncology: Pathophysiology of Cardiometabolic Outcomes in Cancer PatientsVincenzo Quagliariello, Nicola Maurea, Maria Laura Canale et al.|International Journal of Molecular Sciences|2024Cited by 18
Combinatorial immune checkpoint blockade increases myocardial expression of NLRP-3 and secretion of H-FABP, NT-Pro-BNP, interleukin-1β and interleukin-6: biochemical implications in cardio-immuno-oncologyVincenzo Quagliariello, Nicola Maurea, Margherita Passariello et al.|Frontiers in Cardiovascular Medicine|2024Cited by 16
The sGCa Vericiguat Exhibit Cardioprotective and Anti-Sarcopenic Effects through NLRP-3 Pathways: Potential Benefits for Anthracycline-Treated Cancer PatientsVincenzo Quagliariello, Nicola Maurea, Massimiliano Berretta et al.|Cancers|2024Cited by 14